Entropy-driven amplification combined with CRISPR-Cas12a to develop a dual-mode biosensor for breast cancer miR-155 detection
Microchimica Acta · 2026-11 · 193 (11)
DOI: 10.1007/s00604-026-08451-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microchimica Acta, online erschienen am 08.10.2026. Verfasst von Yihua Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, the Affiliated Hospital, Southwest Medical University, Luzhou, China. Hauptthemen laut MEDLINE: MicroRNAs, Biosensing Techniques, Breast Neoplasms, CRISPR-Cas Systems. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Scientific research and development center of colleges and universities of the Ministry of Education, The Project of Medical Association of Sichuan Province, Science and Technology Department of Sichuan Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, the Affiliated Hospital, Southwest Medical University, Luzhou, China.
- Molecular Diagnosis of Clinical Diseases Key Laboratory of Luzhou, Luzhou , China.
- Sichuan Province Engineering Technology Research Center of Molecular Diagnosis of Clinical Diseases, Luzhou, China.
- Department of Clinical Laboratory, School of Medicine, Mianyang Central Hospital, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.
- Department of Laboratory Medicine, the Affiliated Hospital, Southwest Medical University, Luzhou, China. liujb7203@swmu.edu.cn.
- Molecular Diagnosis of Clinical Diseases Key Laboratory of Luzhou, Luzhou , China. liujb7203@swmu.edu.cn.
Förderung
- Scientific research and development center of colleges and universities of the Ministry of Education
- The Project of Medical Association of Sichuan Province
- Science and Technology Department of Sichuan Province
- Health Commission of Sichuan Province
Zitieren
APA
Wang, Y., Lan, M., Zhong, M., Jiang, H., Wang, Q., Liu, J., & Li, B. (2026). Entropy-driven amplification combined with CRISPR-Cas12a to develop a dual-mode biosensor for breast cancer miR-155 detection. Microchimica Acta, 193(11). https://doi.org/10.1007/s00604-026-08451-3
Vancouver
Wang Y, Lan M, Zhong M, Jiang H, Wang Q, Liu J, et al. Entropy-driven amplification combined with CRISPR-Cas12a to develop a dual-mode biosensor for breast cancer miR-155 detection. Microchimica Acta. 2026;193(11). doi:10.1007/s00604-026-08451-3
BibTeX
@article{Wang2026,
author = {Wang, Yihua and Lan, Min and Zhong, Min and Jiang, Hui and Wang, Qi and Liu, Jinbo and Li, Baolin},
title = {Entropy-driven amplification combined with CRISPR-Cas12a to develop a dual-mode biosensor for breast cancer miR-155 detection},
journal = {Microchimica Acta},
year = {2026},
volume = {193},
number = {11},
doi = {10.1007/s00604-026-08451-3}
}
EUVIMED